ACURA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ACURA PHARMA
Largest movements
- Receivables within one year -€54,205
down €54,205 (-77.6%), from €69,821 to €15,616
of which Trade receivables: -€46,953
- Tangible fixed assets -€19,292
down €19,292 (-11.0%), from €176,030 to €156,738
of which Land and buildings: -€19,543
- Cash +€19,054
up €19,054 (+34.3%), from €55,514 to €74,568
mainly Net result for the year (+€69,807) and Receivables within one year (+€54,205)
- Stocks and contracts +€12,589
up €12,589 (+11.8%), from €106,270 to €118,859
- Reserves +€69,807
up €69,807 (+261%), from €26,733 to €96,540
of which Distributable reserves: +€69,807
- Other debts -€69,149
down €69,149 (-46.8%), from €147,734 to €78,585
- Debts after one year -€34,346
down €34,346 (-23.9%), from €143,819 to €109,473
- Trade debts -€12,197
down €12,197 (-31.2%), from €39,144 to €26,947
- Gross operating margin -€36,471
down €36,471 (-20.7%), from €176,002 to €139,532
- Staff costs +€19,166
new in 2025: €19,166
- Taxes -€12,202
down €12,202 (-32.4%), from €37,704 to €25,502
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €408,192 | €366,408 | -€41,783 | -10.2% |
| Fixed assets | 21/28 | €176,030 | €156,738 | -€19,292 | -11.0% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €176,030 | €156,738 | -€19,292 | -11.0% |
| Land and buildings | 22 | €175,559 | €156,016 | -€19,543 | -11.1% |
| Plant, machinery and equipment | 23 | €0 | €0 | = | |
| Furniture and vehicles | 24 | €472 | €722 | +€251 | +53.2% |
| Current assets | 29/58 | €232,161 | €209,670 | -€22,491 | -9.7% |
| Stocks and contracts in progress | 3 | €106,270 | €118,859 | +€12,589 | +11.8% |
| Stocks | 30/36 | €106,270 | €118,859 | +€12,589 | +11.8% |
| Amounts receivable within one year | 40/41 | €69,821 | €15,616 | -€54,205 | -77.6% |
| Trade receivables | 40 | €47,936 | €983 | -€46,953 | -97.9% |
| Other amounts receivable | 41 | €21,886 | €14,634 | -€7,252 | -33.1% |
| Cash at bank and in hand | 54/58 | €55,514 | €74,568 | +€19,054 | +34.3% |
| Deferred charges and accrued income | 490/1 | €556 | €628 | +€71 | +12.8% |
| Total equity and liabilities | 10/49 | €408,192 | €366,408 | -€41,783 | -10.2% |
| Equity | 10/15 | €33,733 | €103,540 | +€69,807 | +207% |
| Contributions | 10/11 | €7,000 | €7,000 | = | 0.0% |
| Reserves | 13 | €26,733 | €96,540 | +€69,807 | +261% |
| Non-distributable reserves | 130/1 | €2,000 | €2,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €2,000 | €2,000 | = | 0.0% |
| Distributable reserves | 133 | €24,733 | €94,540 | +€69,807 | +282% |
| Amounts payable | 17/49 | €374,458 | €262,868 | -€111,590 | -29.8% |
| Amounts payable after more than one year | 17 | €143,819 | €109,473 | -€34,346 | -23.9% |
| Financial debts | 170/4 | €143,819 | €109,473 | -€34,346 | -23.9% |
| Amounts payable within one year | 42/48 | €230,639 | €153,395 | -€77,244 | -33.5% |
| Current portion of amounts payable after more than one year | 42 | €36,051 | €37,161 | +€1,111 | +3.1% |
| Trade debts | 44 | €39,144 | €26,947 | -€12,197 | -31.2% |
| Suppliers | 440/4 | €39,144 | €26,947 | -€12,197 | -31.2% |
| Taxes, remuneration and social security | 45 | €7,711 | €10,702 | +€2,991 | +38.8% |
| Taxes | 450/3 | €7,711 | €10,702 | +€2,991 | +38.8% |
| Other amounts payable | 47/48 | €147,734 | €78,585 | -€69,149 | -46.8% |
| Remuneration, social security and pensions | 62 | - | €19,166 | +€19,166 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,804 | €20,176 | -€627 | -3.0% |
| Other operating charges | 640/8 | €387 | €487 | +€100 | +25.8% |
| Gross operating margin | 9900 | €176,002 | €139,532 | -€36,471 | -20.7% |
| Operating profit (loss) | 9901 | €154,812 | €99,702 | -€55,109 | -35.6% |
| Financial income | 75/76B | €12 | €1,389 | +€1,378 | +11,776% |
| Recurring financial income | 75 | €12 | €1,389 | +€1,378 | +11,776% |
| Financial charges | 65/66B | €6,384 | €5,782 | -€601 | -9.4% |
| Recurring financial charges | 65 | €6,384 | €5,782 | -€601 | -9.4% |
| Profit (loss) for the period before taxes | 9903 | €148,439 | €95,309 | -€53,130 | -35.8% |
| Income taxes | 67/77 | €37,704 | €25,502 | -€12,202 | -32.4% |
| Profit (loss) for the period | 9904 | €110,735 | €69,807 | -€40,928 | -37.0% |
| Profit (loss) for the period to be appropriated | 9905 | €110,735 | €69,807 | -€40,928 | -37.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.